Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CPA1 | P15085 | 7/20 | 0.76 |
| ▸ | CPA3 | P15088 | 3/20 | 0.76 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.76 |
| ▸ | CPB1 | P15086 | 1/20 | 0.76 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.76 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.68 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.68 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.68 |
| ▸ | MME | P08473 | 1/20 | 0.63 |
| ▸ | ALPI | P09923 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.61 |
| ▸ | XIAP | P98170 | 1/20 | 0.61 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.61 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9875948 | 0.98 | CYP1A2 (0.95) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL27291058 | 0.98 | CYP1A2 (0.95) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL22115491 | 0.98 | CYP1A2 (0.95) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL9622038 | 0.93 | CYP1A2 (0.86) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL7439697 | 0.93 | CYP1A2 (0.86) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL7432418 | 0.93 | CYP1A2 (0.86) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL265514 | 0.91 | CYP1A2 (0.83) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL491524 | 0.91 | CYP1A2 (0.83) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL265063 | 0.91 | CYP1A2 (0.83) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL19821208 | 0.91 | CYP1A2 (0.83) | CYP1A2CPA1CPA3FOLH1CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3197948-B1 | MONOBENZOATE ANALOGS USEFUL AS PLASTICIZERS IN PLASTISOL COMPOSITIONS | EMERALD KALAMA CHEMICAL LLC (US) | 2020-04-01 | — | — | EP | claimed |
| CN-107602406-B | Preparation method and content control method in racecadotril as two kinds of impurity of external standard | 陕西汉江药业集团股份有限公司 | 2019-08-20 | — | — | CN | claimed |
| CN-106833773-B | M20 methanol gasoline modified alcohol additives | 甘肃桑田清洁能源开发有限公司 | 2018-05-18 | — | — | CN | claimed |
| CN-107602406-A | In racecadotril as external standard two kinds of impurity preparation method and content control method | 陕西汉江药业集团股份有限公司 | 2018-01-19 | — | — | CN | claimed |
| CN-106833773-A | M20 methanol gasoline modified alcohol additives | 甘肃桑田清洁能源开发有限公司 | 2017-06-13 | — | — | CN | claimed |
| JP-63209884-A | — | — | None | — | — | JP | disclosed |
| EP-4702033-A1 | DESMURAMYLPEPTIDE DIACIDS AS NOD2 AGONISTS AND USE THEREOF | Imhotex Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024224086-A1 | DESMURAMYLPEPTIDE DIACIDS AS NOD2 AGONISTS AND USE THEREOF | Imhotex Limited (GB) | 2024-10-31 | — | — | WO | disclosed |
| EP-3440051-B1 | NEUROPEPTIDE S RECEPTOR (NPSR) AGONISTS | RES TRIANGLE INST (US) | 2024-03-20 | — | — | EP | disclosed |
| CN-117088744-A | Method for constructing fluorine-containing compound by catalyzing decarboxylation of alkyl carboxylic acid by ketone compound | 中山大学 | 2023-11-21 | — | — | CN | disclosed |
| CN-114796219-A | Compound pharmaceutical composition for treating glaucoma and application thereof | 沈阳药科大学 | 2022-07-29 | — | — | CN | disclosed |
| CN-109153635-B | Neuropeptide S receptor (NPSR) agonists | 研究三角协会 | 2022-04-08 | — | — | CN | disclosed |
| EP-0212903-A2 | Polypeptide derivatives containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues | PFIZER INC. (US) | 1987-03-04 | — | — | EP | disclosed |
| US-4645759-A | HYPOTENSIVE AGENTS | ABBOTT LABORATORIES (US) | 1987-02-24 | — | — | US | disclosed |
| EP-0189203-A2 | Peptidylaminodiols | ABBOTT LABORATORIES (US) | 1986-07-30 | — | — | EP | disclosed |
| EP-0181110-A2 | Histidine derivatives as renin inhibitors | Kissei Pharmaceutical Co. Ltd. (JP) | 1986-05-14 | — | — | EP | disclosed |
| EP-0172346-A2 | Renin inhibiting compounds | ABBOTT LABORATORIES (US) | 1986-02-26 | — | — | EP | disclosed |
| EP-0172347-A2 | Renin inhibiting compounds | ABBOTT LABORATORIES (US) | 1986-02-26 | — | — | EP | disclosed |
| US-4297438-A | USING HYDROPHILIC AND HYDROPHOBIC DEVELOPERS COMPRISING N-SULFOALKYL-N-ALKYL-P-DIAMINOBENZENES | AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) | 1981-10-27 | — | — | US | disclosed |
| US-3998641-A | A 2-CYCLOTETRAMETHYLENE SULFONE-CONTAINING BETA-KETOACETANILIDE | AGFA-GEVAERT, A.G. (DT) | 1976-12-21 | — | — | US | disclosed |